A successful virus infection usually involves entry into the cell; uncoating, expression and replication of the genome; assembly and release of infectious virus particles; and defense against specific and non-specific host immune mechanisms. Some genes are required for replication in any cell, whereas others are only important in certain ones. Still other genes have no role in vitro and are advantageous only during animal infection. Studies during the past year have contributed to our understanding of the mechanism of virus entry. Evidence was obtained that both intra- and extracellular forms of vaccinia virus fuse with the cell membrane in a pH independent manner. A large number of genes that are not required for growth in tissue culture have been identified. The conservation of these genes in vaccinia virus and other members of the orthopoxvirus genus signifies that the protein products have an important role in virus-host interactions. We have given the name virokine to one class of such proteins that are secreted from infected cells. The first member of this class is the vaccinia virus growth factor, VGF. We have identified two additional members. One is a 35,000 molecular weight protein that has both structural and functional similarities to the human complement 4b binding protein. The viral protein is able to bind to C4b and to block the classical complement pathway in vitro and may provide defense against the host immune system. Another protein of this class has a molecular weight of 14,000. Although the function of the protein of this class has a molecular weight of 14,000. Although the function of the protein is unknown, deletion of the gene attenuates the pathogenicity of vaccinia virus for mice.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000539-03
Application #
3809706
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Wagenaar, Timothy R; Moss, Bernard (2009) Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion. J Virol 83:1546-54
Resch, Wolfgang; Weisberg, Andrea S; Moss, Bernard (2009) Expression of the highly conserved vaccinia virus E6 protein is required for virion morphogenesis. Virology 386:478-85
Nelson, Gretchen E; Wagenaar, Timothy R; Moss, Bernard (2008) A conserved sequence within the H2 subunit of the vaccinia virus entry/fusion complex is important for interaction with the A28 subunit and infectivity. J Virol 82:6244-50
Wagenaar, Timothy R; Ojeda, Suany; Moss, Bernard (2008) Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex. J Virol 82:5153-60
Resch, Wolfgang; Hixson, Kim K; Moore, Ronald J et al. (2007) Protein composition of the vaccinia virus mature virion. Virology 358:233-47
Husain, Matloob; Weisberg, Andrea S; Moss, Bernard (2007) Sequence-independent targeting of transmembrane proteins synthesized within vaccinia virus factories to nascent viral membranes. J Virol 81:2646-55
Wagenaar, Timothy R; Moss, Bernard (2007) Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex. J Virol 81:6286-93
Husain, Matloob; Weisberg, Andrea S; Moss, Bernard (2007) Resistance of a vaccinia virus A34R deletion mutant to spontaneous rupture of the outer membrane of progeny virions on the surface of infected cells. Virology 366:424-32
Charity, James C; Katz, Ehud; Moss, Bernard (2007) Amino acid substitutions at multiple sites within the vaccinia virus D13 scaffold protein confer resistance to rifampicin. Virology 359:227-32
Townsley, Alan C; Moss, Bernard (2007) Two distinct low-pH steps promote entry of vaccinia virus. J Virol 81:8613-20

Showing the most recent 10 out of 69 publications